Correction: Ipilimumab plus nivolumab for patients with metastatic uveal melanoma: a multicenter, retrospective study

Ferté, Charles; Frey, Benjamin; Hecht, Markus; Fietkau, Rainer; Sundahl, Nora; Putz, Florian; Lancia, Andrea; Rouyar, Angéla; Milić, Marina; Carré, Alexandre; Battistella, Enzo; Alvarez Andres, Émilie; Niyoteka, Stéphane; Romano, Edouard; Durand-Labrunie, Jérôme; Bockel, Sophie; Bahleda, Rastilav; Robert, Caroline; Boutros, C.; Vakalopoulou, Maria; Paragios, Nikos; Ost, Piet; S. Gaipl, Udo

doi:10.1136/jitc-2019-000331corr1

Public

Correction: Ipilimumab plus nivolumab for patients with metastatic uveal melanoma: a multicenter, retrospective study

Published in Journal for ImmunoTherapy of Cancer • Nov 1, 2020

Authors:

Charles Ferté

Benjamin Frey

Markus Hecht

Abstract

Najjar YG, Navrazhina K, Ding F, et al . Ipilimumab plus nivolumab for patients with metastatic uveal melanoma: a multicenter, retrospective study. J Immunother Cancer 2020;8:e000331. doi: 10.1136/jitc-2019-000331 This article has been corrected since it was published online. The author, Igor

Subject

Ipilimumab

Nivolumab

Medicine

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!